Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | plexin A | 0.0112 | 0.2715 | 0.2715 |
Schistosoma mansoni | hypothetical protein | 0.0074 | 0.1273 | 0.6162 |
Loa Loa (eye worm) | hypothetical protein | 0.0307 | 1 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 kinase regulatory subunit | 0.0078 | 0.1442 | 0.5312 |
Loa Loa (eye worm) | hypothetical protein | 0.0095 | 0.2065 | 0.2065 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0583 | 0.0583 |
Brugia malayi | Plexin repeat family protein | 0.0095 | 0.2065 | 0.2065 |
Echinococcus granulosus | expressed conserved protein | 0.0074 | 0.1273 | 0.4688 |
Schistosoma mansoni | plexin | 0.0095 | 0.2065 | 1 |
Echinococcus granulosus | plexin a4 | 0.0112 | 0.2715 | 1 |
Schistosoma mansoni | plexin | 0.0055 | 0.0583 | 0.2822 |
Schistosoma mansoni | hypothetical protein | 0.0055 | 0.0583 | 0.2822 |
Onchocerca volvulus | 0.0095 | 0.2065 | 1 | |
Echinococcus granulosus | phosphatidylinositol 3 kinase regulatory subunit | 0.0078 | 0.1442 | 0.5312 |
Loa Loa (eye worm) | plexin A | 0.0112 | 0.2715 | 0.2715 |
Echinococcus multilocularis | expressed conserved protein | 0.0074 | 0.1273 | 0.4688 |
Echinococcus multilocularis | plexin a4 | 0.0112 | 0.2715 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | In vitro Agonistic activity of the compound was determined against histamine H3 receptor from rat cerebral cortex synaptosomes; Partial agonist | ChEMBL. | 15163206 | |
Activity (functional) | In vivo Agonistic activity of the compound was determined against histamine H3 receptor mice; Partial agonist | ChEMBL. | 15163206 | |
Activity (functional) | 0 | In vitro Agonistic activity of the compound was determined against histamine H3 receptor from rat cerebral cortex synaptosomes; Partial agonist | ChEMBL. | 15163206 |
Activity (functional) | 0 | In vivo Agonistic activity of the compound was determined against histamine H3 receptor mice; Partial agonist | ChEMBL. | 15163206 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.